India’s Nicholas Piramal India Limited In Drug Pact With Eli Lilly and Company

January 12, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, Jan 12 (Reuters) - Indian drug maker Nicholas Piramal Ltd. (NICH.BO: Quote, Profile , Research) said on Friday it had reached a drug-development agreement with Eli Lilly and Co. (LLY.N: Quote, Profile , Research).

>>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia